Showing 71-80 of 1732 results for "".
Migraine Mimics
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-mimics/31510/Are we underdiagnosing migraines?Diagnostic & Treatment Delay in Temporal Lobe Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-treatment-delay-in-temporal-lobe-epilepsy/31835/The average 20-year delay of referral to epilepsy centers can be improved.Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-dementia-and-psychosis-in-individuals-with-parkinson-disease/37654/A review highlighting the clinical features of dementia and psychosis in people with Parkinson disease and diagnostic and therapeutic strategies for the management of these conditions.Fluid Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fluid-biomarkers-in-multiple-sclerosis/36255/Fluid biomarkers may allow for improvement in diagnosis, prognostication, and monitoring of disease activity and treatment response in multiple sclerosis while reducing reliance on imaging.Viewpoints: The Neurology of FDR
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/viewpoints-the-neurology-of-fdr/30571/Did the only person ever elected to the presidency four times have Guillain-Barré syndrome and epilepsy?Forward Thinking: Advances in Neurology
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/forward-thinking-advances-in-neurology/30305/A review of notable neurological developments in 2017 and a preview of the year ahead.Pharmacologic Considerations in the Treatment of Older Adults With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacologic-considerations-in-the-treatment-of-older-adults-with-epilepsy/32176/Many antiseizure medications are available for treatment of older adults with epilepsy, and choosing the best option requires understanding of their pharmacokinetic and pharmacodynamic properties.Monoclonal Antibody Therapy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monoclonal-antibody-therapy-in-multiple-sclerosi/30209/Finding the forest among the trees with an update on the safety, efficacy, and mechanisms of monoclonal antibodies.Access to Newer AEDs and Specialists are Key to Seizure Control
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/access-to-newer-aeds-and-specialists-are-key-to-seizure-control/30541/A new report shows that some patients still lack access to care resources.Neurologic Complications of Globally Prevalent Infectious Disorders: A Focus on Syphilis, Cysticercosis, and Tuberculosis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neurologic-complications-of-globally-prevalent-infectious-disorders-a-focus-on-syphilis-cysticercosis-and-tuberculosis/32153/In the presence of CNS infections, neurologists should have a high index of suspicion for syphilis, tuberculosis, or cysticercosis, especially in people from endemic areas and immunocompromised individuals.